Tilos Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Tilos Therapeutics is a small biotechnology company focused on developing antibodies that target LAP to treat cancer, with early research in fibrosis and autoimmune disease. The approach centers on anti-LAP antibodies designed to modulate immune regulation and support anti-tumor activity. This work builds on decades of foundational research by its scientists into LAP-expressing cells and their role in immune control, with the aim of advancing candidates into clinical development.